Skip to main content
. 2022 Jul 11;2(7):616–623. doi: 10.1158/2767-9764.CRC-22-0137

FIGURE 1.

FIGURE 1

DLL3 is expressed in neuroblastoma and other pediatric solid tumors. Boxplots displaying DLL3 expression (log2 FPKM) in patients with high-risk neuroblastoma (n = 126), SCLC (n = 79), and other pediatric solid tumors (n = 292; A). B,DLL3 expression in solid tumors were compared with normal tissue expression data extracted from the GTEx consortium (n = 7,859 samples, across 31 unique tissues). The number of samples of each tissue is within the parentheses on the X-axis.